Silenseed Competitors and Similar CompaniesClear all
Silenseed's competitors and similar companies include Nektar Therapeutics and Heidelberg Pharma.
 Silenseed Silenseed is a biopharmaceutical company developing RNA interference (RNAi)-based cancer drugs. |  Heidelberg Pharma Heidelberg Pharma is a drug development company that provides pre-clinical drug discovery and development services for the development of anti-cancer and anti-inflammatory drugs to pharmaceutical and biotechnology industries. | ||
Founding Date | Founding Date 1999 | Founding Date 1990 | Founding Date 1997 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Modi'in-Maccabim-Re'ut, IL HQ | Locations San Francisco, US HQ Hyderabad, IN Huntsville, US | Locations Ladenburg, DE HQ Ladenburg, DE |
Employees | Employees 4 | Employees 61821% increase | Employees 60 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 233.8 m | Valuation ($) 158.3 m |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $55.2m (FY, 2025) | Revenue (est.) €1.5m (FY, 2025) |
Net income | Net income N/A | Net income ($164.1m) (FY, 2025) | Net income (€42.3m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 10.5m | Total funding raised $ 45m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Nektar Therapeutics
HQ
San Francisco, US
Employees
618↑ 21% increase
Nektar Therapeutics is a stage-clinical biopharmaceutical company.
View companyHeidelberg Pharma
HQ
Ladenburg, DE
Employees
60
Heidelberg Pharma is a drug development company that provides pre-clinical drug discovery and development services for the development of anti-cancer and anti-inflammatory drugs to pharmaceutical and biotechnology industries.
View company